- Conditions
- B-cell Acute Lymphocytic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +20 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Relapsed/Refractory
Explore clinical trials studying Relapsed/Refractory. Study availability and eligibility vary by location and protocol.
6 public trials
3 recruiting studies
Relapsed/Refractory trial results
NCT06999031
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
NCT06581640
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Not Yet Recruiting
IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia
NCT07585071
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +10 more
- Locations
-
Not specified
Completed
Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias
NCT05969002
- Conditions
- Acute Lymphoblastic Leukemia, B Cell, Disease Attributes, +15 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- City of Hope - Duarte Duarte, California, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center New York, United States
- Weill Cornell Medical Center, Div. of Hematology Medical Oncology New York, United States